Exploring the Potential and Challenges of mRNA Technology in Revolutionizing Flu Vaccines
The article discusses the potential of mRNA technology, popularized during the COVID-19 pandemic, in revolutionizing flu [...]
Respiratory Viruses Return to Seasonal Patterns After Covid-19 Disruption
During the height of the COVID-19 pandemic, other respiratory viruses such as the flu, RSV, and [...]
Reagan-Udall Foundation Calls for Overhaul of Post-Market Evidence Generation System, Suggests FDA-Led Approach
The Reagan-Udall Foundation asserts in a new report that the current post-market evidence generation system is [...]
FDA Issues Draft Guidance Recognizing the Role of Real-World Evidence in Learning More about Populations Underrepresented in Clinical Trials for Drugs and Biological Products
By: Ulka Campbell, Head of Scientific Strategy, Aetion Of the many potential use cases for real-world data (RWD) [...]
The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
Global Real-World Data Market Forecast to Grow at 14.4% CAGR from 2023 to 2030, Fueled by Increased Demand for Evidence-based Medicine and Technological Advancements
The global real-world data (RWD) market, which encompasses data collected outside of clinical trials, is forecasted to grow at a [...]
Between Two Scientists: Data Linkage – Like Making a Fine, Blended Wine from Varietal Data Sources
This episode of tHEORetically Speaking features host Meg Richards, Executive Director of Solutions at Panalgo, who speaks with Erik Maul, Senior Director of Data Partnerships at Panalgo about data linkage.
Galecto Laying Off 70% of Staff and Exploring Strategic Alternatives after Failed Lung Disease Drug Trial
Boston-based biotech firm Galecto plans to lay off 29 employees, approximately 70% of its workforce, after [...]
Class-Action Lawsuit Targets Johnson & Johnson and IBM after Data Breach
Johnson & Johnson and IBM face a proposed class-action lawsuit following a data breach at J&J’s [...]
Higher Suicide Risk Among Health Care Workers, Especially Women: Study Reveals
A new study in the Journal of the American Medical Association suggests that health care workers, [...]
Christine Davis Appointed as New President of Ontada
Ontada, a McKesson business focusing on oncology real-world data and evidence, has appointed Christine Davis as [...]
The Sooner, the Better: Detecting and Decoding Alzheimer’s with Real-World Data
The landscape for Alzheimer’s disease is rapidly changing. This episode of tHEORetically speaking features Dr. Carl Marci from OM1 and Dr. Luke Stoeckel from NIA, as they discuss the critical need for earlier detection leading to potentially life changing earlier interventions.
FDA Updates Guidelines on Using Single Clinical Investigation as Confirmatory Evidence for New Drug Approval
The FDA has issued a draft guide to clarify how evidence from a sole clinical investigation [...]
Alexion Pharmaceuticals Nears $125M Settlement in Class Action Lawsuit Over Alleged Unethical Sales Practices
A 2016 class action lawsuit against pharmaceutical company Alexion, which claimed that the company's unethical sales [...]
Ongoing Medicare Privatization Will Hurt Pharma As Much As the IRA
The pharmaceutical industry is in a frenzy over the recently released list of the drugs subject to [...]
Cognitive Ability Tied to COVID-19 Vaccination Rates
The study published in the Journal of Health Economics investigated a link between an individual's cognitive [...]
AI-Enhanced Testing: Transforming the Landscape of Software Quality Assurance
Traditional test automation has limitations in replicating real-world user behavior and interactivity, which results in a need for an [...]
Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases
Watch this webinar exploring real challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases to support clinical development through commercial post-approval.
FDA Releases Guidance on Utilizing Real-World Evidence for Pharmaceutical Regulatory Review Process
The FDA has published final draft guidance for pharmaceutical companies, indicating how they can use real-world evidence to support their [...]
Atropos Health Expands into Life Sciences Sector
Atropos Health, acclaimed for its Green Button Clinical Informatics Consult Service, is expanding into the life sciences sector. It will [...]
Target RWE to Showcase Innovative Epidemiology Research and Launch Syndicated Science™ Insights
Target RWE, a leader in real-world evidence, will present innovative research in epidemiology and statistics at the International Society for [...]
FDA Approves Ipsen’s Ultra-Rare Bone Disease Drug Sohonos
The Food and Drug Administration (FDA) has approved Ipsen Pharmaceuticals' Sohonos, a drug designed to treat fibrodysplasia ossificans progressiva (FOP), [...]
Keeping pace with RWE: What do regulators, payers, and patients want?
Keeping pace with RWE: What do regulators, payers, and patients want? A wide range of key stakeholders have started embracing [...]
Segmed Exceeds 100 Million Imaging Studies Milestone on Its Network
Segmed, a company that focuses on simplifying access to real-world medical imaging data (RWiD), has announced its network has surpassed [...]
